Circulating microbiome in blood of different circulatory compartments
Open Access
Abstract
We read with interest the recent review by Tilg et al ,1 which summarised the role of microbiota in liver diseases and pointed out that a causal link with systemic inflammation has still not been established. This letter fills in this gap and provides an analysis of the circulating microbiota in portal vein as the link between gut and liver. The access to portal circulation is possible during the implantation of a transjugular intrahepatic portosystemic shunt (TIPS). Therefore, we characterised the circulating microbiome in portal vein (first venous outflow in gut–liver axis), liver outflow, central venous blood and peripheral venous blood from seven patients with decompensated liver cirrhosis receiving TIPS for either variceal bleeding (n=3) or refractory ascites (n=4) (mean Model for End-stage Liver Disease (MELD) 8.4 (range 6–13), Child-Pugh-Score (CHILD) A: n=4, CHILD B: n=3) (figure 1A). We performed 16S ribosomal RNA (rRNA) gene sequencing of buffy coat samples and identified 65 genera belonging to four phyla (predominantly Proteobacteria) in this cohort (online supplementary figure 1 and figure 1B …Keywords
Funding Information
- Horizon 2020 Framework Programme
- Novo Nordisk Foundation
- Deutsche Forschungsgemeinschaft
- CELLEX Foundation
This publication has 10 references indexed in Scilit:
- Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortalityHepatology, 2018
- Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortalityLiver International, 2017
- Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosisGut, 2017
- Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysisHepatology, 2016
- Gut microbiome and liver diseasesGut, 2016
- Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failureHepatology, 2016
- Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosisGut, 2016
- Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencingTransfusion, 2016
- CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shuntJournal of Hepatology, 2015
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biology, 2014